Response to Grosse et  al.

To the Editor: We thank Dr. Grosse and colleagues for two corrections to the introduction of our recent description of a genome-sequencing system for universal newborn screening (NBS), diagnosis, and precision medicine for severe childhood genetic diseases that currently have effective therapeutic interventions.1 Firstly, that between 2006 and 2022, the number of core disorders recommended for NBS of dried blood spots (DBSs) in the United States —the Recommended Uniform Screening Panel (RUSP)—increased by six and not eight, as we had stated.

Source: The American Journal of Human Genetics - June 1, 2023 Category: Genetics & Stem Cells Authors: Stephen F. Kingsmore, Laurie D. Smith, Chris M. Kunard, Matthew Bainbridge, Sergey Batalov, Wendy Benson, Eric Blincow, Sara Caylor, Christina Chambers, Guillermo Del Angel, David P. Dimmock, Yan Ding, Katarzyna Ellsworth, Annette Feigenbaum, Erwin Frise, Tags: Letter to the editor Source Type: research